openPR Logo
Press release

Coronary Artery Disease Therapeutics Market Is Expected To Witness Significant Growth Due To Robust Pipeline Of Drugs Over The Forecast Period 2018-2026

10-11-2018 12:49 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Clinical Diagnostic

Coronary Artery Disease Therapeutics Market

Coronary Artery Disease Therapeutics Market

Coronary Artery Disease (CAD) is a medical condition developed due to damaged or diseased blood vessels, which supply blood, nutrients, and oxygen to the heart. Coronary heart disease is characterized by deposition of cholesterol plague in the arteries, which results into inflammation. Increasing deposition of plague eventually narrows the coronary arteries thereby decreasing the blood flow to the heart. Decrease of blood flow to the heart causes shortness of breath and chest pain leading to heart attack after complete blockage. Coronary artery disease is caused by smoking, high blood pressure, high cholesterol, diabetes or insulin resistance, sedentary lifestyle, and hypertension. Other factors involved in developing coronary artery disease include obesity, physical inactivity, high stress, and unhealthy diet.

Download PDF Brochure of Research report: https://www.coherentmarketinsights.com/insight/request-pdf/1799

Coronary artery disease can be prevented by maintaining healthy diet, consumption of low fat and low salt fruits and vegetables, physical activity, and management of stress. Treatment of coronary artery disease includes cholesterol modifying medications, ACE inhibitors, Aspirin, beta blockers, Calcium channel blockers, and Ranolazine. Surgeries conducted to treat coronary artery disease include Nitroglycerin, Angioplasty, and coronary artery bypass surgery.

Coronary Artery Disease Therapeutics - Top Key Players Operating Global Market
Astra Zeneca, Gilead, Novartis, Pfizer, Bayer, Merck & Co, Glaxo Smith Kline, and Mylan N.V.

Coronary Artery Disease Therapeutics Market Drivers:-

The global market is expected to witness significant growth due to robust pipeline of drugs over the forecast period (2018-2026). For instance, hydroxychloroquine sulfate tablets sponsored by first affiliated hospital of Xi’an Jiaotong university, China is in the fourth phase of clinical trials, this drug suppresses symptoms of coronary artery disease. Atorvastatin sponsored by university health network, Toronto has completed phase two clinical trials in 2014, this drug reduces the risk of heart attack and myocardial infraction. PADMA 28 sponsored by University hospital Inselsiptal, Berne has completed phase 2 clinical trials in 2013, this drug has beneficial effect on arterial system, the autonomic nervous system and blood inflammatory markers in patients with coronary artery disease.

However, high cost of new drugs is restraining growth of coronary artery disease therapeutics market. For instance, Entresto was launched by Novartis, a U.S.-based company, indicated for preventing heart failures. It is priced at US$ 492 for 60 tablets, which is not affordable to low and middle income population.

Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1799

Coronary Artery Disease Therapeutics Market Taxonomy:-

The global market is segmented based on drug type, distribution channel and region.

By Drug Type:-

Beta Blockers
Calcium Channel Blockers
ACE Inhibitors
Nitrates
Statin
Others

By Region:-

North America
Europe
Latin America
Asia Pacific
Middle East
Africa

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Coronary Artery Disease Therapeutics Market Is Expected To Witness Significant Growth Due To Robust Pipeline Of Drugs Over The Forecast Period 2018-2026 here

News-ID: 1296764 • Views:

More Releases from Coherent Market Insights - Clinical Diagnostic

Western Blotting Market is Expected to Gain Popularity Across the Globe by 2026
Western Blotting Market is Expected to Gain Popularity Across the Globe by 2026
Western blotting is a technique used for detection of protein. It is also called as immunoblotting technique wherein specific antibodies are used to detect antigens. It works on the principle of molecular weight of the proteins and specificity. Gel electrophoresis is used for the denaturation of proteins and to obtain the primary antibody. Blotting and testing is performed later where the primary antibody binds to its specific antigen. It gives
Western Blotting Market: Future and Technological Advancement 2026 By Top Players Thermo Fischer Scientific, Aviva Systems Biological Corporation, CANDOR Bioscience GmbH, Bio-Rad Laboratories, Precision Biosystems
Western Blotting Market: Future and Technological Advancement 2026 By Top Player …
Western blotting is a technique used for detection of protein. It is also called as immunoblotting technique wherein specific antibodies are used to detect antigens. It works on the principle of molecular weight of the proteins and specificity. Gel electrophoresis is used for the denaturation of proteins and to obtain the primary antibody. Blotting and testing is performed later where the primary antibody binds to its specific antigen. It gives
Cannabis Testing Market Expansion to be Persistent During 2018 – 2026 With Top Players Like Shimadzu Corporation, Agilent Technologies, Thermo Fisher Scientific, PerkinElmer, Millipore Sigma, AB SCIEX
Cannabis Testing Market Expansion to be Persistent During 2018 – 2026 With Top …
Cannabis testing is done for various purpose such as finding concentration of active ingredient (cannabinoids, terpene), which determines the medical potency of the cannabis. It is also tested for determining various other ingredient in given sample. For instance, to determine the pesticide residue content in the given sample that undermines the purity and efficacy. Cannabis testing also involves determination of contaminants such as fungi and bacteria (mycotoxins), which could causes
Cannabis Testing Market Trends Estimates High Demand By 2026 With Top Key Players Agilent Technologies, Shimadzu Corporation, PerkinElmer, Millipore Sigma, AB SCIEX, Cannabix Technologies, Waters Corporation, Steep Hill Labs
Cannabis Testing Market Trends Estimates High Demand By 2026 With Top Key Player …
Cannabis testing products and services market is witnessing significant growth with increased government approval and loosening regulatory stringent ness over use of cannabis for commercial and recreational purpose. For instance, in February 2016, the Australian government amended the Narcotics Drugs Act 1967, to allow cultivation of cannabis for medicinal or scientific purposes under a national licensing scheme, which is expected to favor the growth of the commercial manufacturing of cannabis

All 5 Releases


More Releases for Coronary

Top Trends Transforming the Coronary Angiography Devices Market Landscape in 202 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Coronary Angiography Devices Industry Market Size Be by 2025? The market for coronary angiography devices has seen significant growth recently. It is projected to expand from $9.43 billion in 2024 to $10.1 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. The growth
Driving Coronary Artery Disease Market Growth in 2025: The Role of The Influence …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Coronary Artery Disease Market Size Growth Forecast: What to Expect by 2025? The market size for coronary artery disease has seen a significant expansion in the past years. A rise from $29.15 billion in 2024, to an estimated $31.97 billion in 2025 at a compound annual growth rate (CAGR)
Major Force in the Coronary Pressure Market 2025: Increasing Cardiovascular Dise …
How Will the Coronary Pressure Market Grow, and What Is the Projected Market Size? In recent years, there has been considerable growth in the size of the coronary pressure market. It is projected to expand from $17.38 billion in 2024 to $19.15 billion in 2025, marking a compound annual growth rate (CAGR) of 10.2%. The growth observed in the historical period is linked to factors such as increased occurrence of cardiovascular
Coronary Balloon Products Market A Less Invasive Path to Open Arteries: The Expa …
Coronary Balloon Products Market worth $1.18 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Coronary Balloon Products Market- (By Product (PTAC balloon, Nc balloon), By Material (Compliant Balloons, Non-Compliant, Semi-Compliant), By End-User (Hospitals, Cardiac Centres, Ambulatory Surgical Centres)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce
Coronary Stent Market - Healthy Hearts, Stronger Lives: Advances in Coronary Ste …
Newark, New Castle, USA: The "Coronary Stent Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Coronary Stent Market: https://www.growthplusreports.com/report/coronary-stent-market/8041 This latest report researches the industry structure, sales, revenue,
Intravascular Ultrasound Systems Market(By Product Type - Ivus Consoles, Ivus Ca …
Intravascular Ultrasound Systems (IVUS) is an imaging method with which we can visualize a coronary artery from the inside out. Intravascular Ultrasound Systems are usually designed in such a way that the individual can have a complete view of the coronary artery blockade using a catheter which is attached to an ultrasound probe at one end and the other end is attached to a computerized ultrasound equipment. The inside out view